These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36056076)

  • 1. Neurotensin analogs by fluoroglycosylation at N
    Schindler L; Wohlfahrt K; Gluhacevic von Krüchten L; Prante O; Keller M; Maschauer S
    Sci Rep; 2022 Sep; 12(1):15028. PubMed ID: 36056076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
    Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
    Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
    Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1.
    Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O
    J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Neurotensin-Derived
    Schindler L; Moosbauer J; Schmidt D; Spruss T; Grätz L; Lüdeke S; Hofheinz F; Meister S; Echtenacher B; Bernhardt G; Pietzsch J; Hellwig D; Keller M
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Neurotensin Receptor in Prostate Cancer With
    Deng H; Wang H; Zhang H; Wang M; Giglio B; Ma X; Jiang G; Yuan H; Wu Z; Li Z
    Mol Imaging; 2017; 16():1536012117711369. PubMed ID: 28849698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
    J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical PET Imaging of NTSR-1-Positive Tumors with
    Li D; Minnix M; Allen R; Bading J; Chea J; Wong P; Bowles N; Poku E; Shively JE
    Cancer Biother Radiopharm; 2021 Oct; 36(8):651-661. PubMed ID: 32822229
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiopharmaceuticals for imaging and endoradiotherapy of neurotensin receptor-positive tumors.
    Maschauer S; Prante O
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):309-325. PubMed ID: 29114915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS
    Fanelli R; Chastel A; Previti S; Hindié E; Vimont D; Zanotti-Fregonara P; Fernandez P; Garrigue P; Lamare F; Schollhammer R; Balasse L; Guillet B; Rémond E; Morgat C; Cavelier F
    Bioconjug Chem; 2020 Oct; 31(10):2339-2349. PubMed ID: 32887526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs.
    Bergmann R; Scheunemann M; Heichert C; Mäding P; Wittrisch H; Kretzschmar M; Rodig H; Tourwé D; Iterbeke K; Chavatte K; Zips D; Reubi JC; Johannsen B
    Nucl Med Biol; 2002 Jan; 29(1):61-72. PubMed ID: 11786277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
    Kühl T; Georgieva MG; Hübner H; Lazarova M; Vogel M; Haas B; Peeva MI; Balacheva AA; Bogdanov IP; Milella L; Ponticelli M; Garev T; Faraone I; Detcheva R; Minchev B; Petkova-Kirova P; Tancheva L; Kalfin R; Atanasov AG; Antonov L; Pajpanova TI; Kirilov K; Gastreich M; Gmeiner P; Imhof D; Tzvetkov NT
    Eur J Med Chem; 2023 Jun; 254():115386. PubMed ID: 37094450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positron Emission Tomography Imaging of Neurotensin Receptor-Positive Tumors with
    Renard E; Moreau M; Bellaye PS; Guillemin M; Collin B; Prignon A; Denat F; Goncalves V
    J Med Chem; 2021 Jun; 64(12):8564-8578. PubMed ID: 34107209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of neurotensin receptor 1 as a potential imaging target in pancreatic ductal adenocarcinoma.
    Yin X; Wang M; Wang H; Deng H; He T; Tan Y; Zhu Z; Wu Z; Hu S; Li Z
    Amino Acids; 2017 Aug; 49(8):1325-1335. PubMed ID: 28536844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
    Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis.
    Bossard C; Souazé F; Jarry A; Bezieau S; Mosnier JF; Forgez P; Laboisse CL
    Peptides; 2007 Oct; 28(10):2030-5. PubMed ID: 17870207
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Wu W; Yu F; Zhang P; Bu T; Fu J; Ai S; You Q; Shi L; Shao G; Wang F; Hodolic M; Guo H
    J Nucl Med; 2022 Sep; 63(9):1394-1400. PubMed ID: 35177423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc.
    Nock BA; Nikolopoulou A; Reubi JC; Maes V; Conrath P; Tourwé D; Maina T
    J Med Chem; 2006 Jul; 49(15):4767-76. PubMed ID: 16854083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.